Also, the association between obesity and PsA is potentially bidirectional, as patients with joint dysfunction are often less physically active [17, 18]
Since compounded medication is not produced by the manufacturer in dosages that have been clinically tested, it's not FDA-approved
Noom, an online weight loss company, is unveiling its Microdose GLP-1 Rx Program, a service intended to limit side effects via personalized microdoses of GLP-1s, when clinically appropriate of course
Diabetes Metab Syndr 19(2):103185 Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T et al (2019) Sarcopenia: revised European consensus on definition and diagnosis
While weight loss doesn't replace MS drugs, managing weight through diet, exercise, and medications like GLP-1 agonists may lead to fewer relapses, less disability, and better responses to standard drug treatments by reducing systemic inflammation, he says